Concurrent hyperfractionated radiotherapy and low-dose daily carboplatin/paclitaxel in patients with early-stage (I/II) non-small-cell lung cancer: Long-term results of a phase II study

Journal of Clinical Oncology

Volumn 23, Issue 28, 2005, Pages 6873-6880

  Jeremić, Branislav ^a   Milicić, Biljana ^a   Acimović, Ljubisa ^a   Milisavljević, Slobodan ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; PACLITAXEL; ANTINEOPLASTIC AGENT;

ARTICLE; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESOPHAGUS DISEASE; FEMALE; FRACTIONATION; HUMAN; LEUKOPENIA; LOW DRUG DOSE; LUNG NON SMALL CELL CANCER; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT RESPONSE; ADULT; AGED; DISEASE COURSE; DRUG ADMINISTRATION; LUNG TUMOR; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; RADIATION DOSE FRACTIONATION; SURVIVAL;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DOSE FRACTIONATION; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PACLITAXEL; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 27244444568     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.22.319     Document Type: Article

References (63)

1. Mountain CF: A new international staging system for lung cancer. Chest 89:225S-233S, 1986
2. Mountain CF: Revisions in the international system for staging lung cancer. Chest 111:1710-1717, 1997
3. Naruke T, Goya T, Tsuchiya R, et al: Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 96:440-447, 1988 [Erratum: J Thorac Cardiovasc Surg 97:350, 1989]
4. Cooper JFD, Pearson FG, Todd TRJ, et al: Radiotherapy alone for patients with operable carcinoma of the lung. Chest 87:289-292, 1985
5. Zhang HX, Yin WB, Zhang LJ, et al: Curative radiotherapy of early operable non-small cell lung cancer. Radiother Oncol 14:89-94, 1989
6. Talton BM, Constable WC, Kersh CR: Curative radiotherapy for technically operable stage I nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 19:15-21, 1990
7. Dosoretz DE, Katin MJ, Blitzer PH, et al: Radiation therapy in the management of medically inoperable carcinoma of the lung: Results and implications for future treatment strategies. Int J Radiat Oncol Biol Phys 25:3-9, 1992
8. Kupelian PA, Komaki R, Allen P: Prognostic factors in the treatment of node-negative nonsmall cell lung carcinoma with radiotherapy alone. Int J Radiat Oncol Biol Phys 36:607-613, 1996
9. Cheung PCF, Mackillop WJ, Dixon P, et al: Involved-field radiotherapy alone for early-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 48:703-710, 2000
10. Haffty BG, Goldberg NB, Gerstley J, et al: Results of radical radiation therapy in clinical stage I, technically operable non-small cell lung cancer. Int J Radiat Oncol Biol Phys 15:69-73, 1988
11. Noordijk EM, vd Poest Clement E, Hermans J, et al: Radiotherapy as an alternative to surgery in elderly patients with resectable lung cancer. Radiother Oncol 13:83-89, 1988
12. Sandler HM, Curran WJ Jr, Turrisi AT III: The influence of tumor size and pre-treatment staging on outcome following radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 19:9-13, 1990
13. Ono R, Egawa S, Suemasu K, et al: Radiotherapy in inoperable stage I lung cancer. Jpn J Clin Oncol 21:125-128, 1991
14. Morita K, Fuwa N, Suzuki Y, et al: Radical radiotherapy for medically inoperable non-small cell lung cancer in clinical stage I: Retrospective analysis of 149 patients. Radiother Oncol 42:31-36, 1997
15. Kaskowitz L, Graham MV, Emami B, et al: Radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 27:517-523, 1993
16. Krol ADG, Aussems P, Noordijk EM, et al: Local irradiation alone for peripheral stage I lung cancer: Could we omit the elective regional nodal irradiation? Int J Radiat Oncol Biol Phys 34:297-302, 1996
17. Sibley GS, Jamieson TA, Marks LB, et al: Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: The Duke experience. Int J Radiat Oncol Biol Phys 40:149-154, 1998
18. Slotman BJ, Karim ABMF: Curative radiotherapy for technically operable stage I nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 29:33-37, 1994
19. Slotman BJ, Antonisse IE, Njo KH: Limited field irradiation in early stage (T1-2N0) non-small cell lung cancer. Radiother Oncol 41:41-44, 1996
20. Hayakawa K, Mitsuhashi N, Nakajima N, et al: Radiation therapy for stage III epidermoid carcinoma of the lung. Lung Cancer 8:213-224, 1992
21. Graham PH, Gebski VJ, Langlands AO: Radical radiotherapy for early nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 31:261-266, 1995
22. Gauden S, Ramsay J, Tripcony L: The curative treatment by radiotherapy alone of stage I non-small cell carcinoma of the lung. Chest 108:1278-1282, 1995
23. Hayakawa K, Mitsuhashi N, Saito Y, et al: Limited field irradiation for medically inoperable patients with peripheral stage I non-small cell lung cancer. Lung Cancer 26:137-142, 1999
24. Rosenthal SA, Curran WJ Jr, Herbert SH, et al: Clinical stage II non-small cell lung cancer treated with radiation therapy alone: The significance of clinically staged ipsilateral hilar adenopathy (N1 disease). Cancer 70:3410-3417, 1992
25. Jeremic B, Classen J, Bamberg M: Radiation therapy alone in technically operable, medically inoperable early stage (I/II) non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 54:119-130, 2002
26. Atagi S, Kawahara M, Ogawara M, et al: Phase II trial of daily low-dose carboplatin and thoracic radiotherapy in elderly patients with locally advanced non-small cell lung cancer. Jpn J Clin Oncol 30:59-64, 2000
27. Jeremic B, Shibamoto Y, Milicic B, et al: Concurrent radiochemotherapy for patients with stage III non-small-cell lung cancer (NSCLC): long-term results of a phase II study. Int J Radiat Oncol Biol Phys 42:1091-1096, 1998
28. Jeremic B, Shibamoto Y, Milicic B, et al: Short-term chemotherapy and palliative radiotherapy for elderly patients with stage IV non-small cell lung cancer: A phase II study. Lung Cancer 24:1-9, 1999
29. Jeremić B, Shibamoto Y, Acimovic LJ, et al: Hyperfractionated radiotherapy alone for clinical stage I nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 38:521-525, 1997
30. Jeremić B, Shibamoto Y, Acimovic LJ, et al: Hyperfractionated radiotherapy for clinical stage II nonsmall cell lung cancer. Radiother Oncol 51:141-145, 1999
31. Jeremić B, Shibamoto Y, Acimovic L, et al: Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer. J Clin Oncol 13:452-458, 1995
32. Jeremić B, Shibamoto Y, Acimovic L, et al: Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/ etoposide for stage III non-small-cell lung cancer: A randomized study. J Clin Oncol 14:1065-1070, 1996
33. Jeremić B, Shibamoto Y, Acimovic LJ, et al: Hyperfractionated radiation therapy and concurrent low-dose, daily carboplatin/etoposide with or without week-end carboplatin/etoposide chemotherapy in stage III non-small-cell lung cancer: A randomized trial. Int J Radiat Oncol Biol Phys 50:19-25, 2001
34. Rowinsky EK, Flood WA, Sartorius SE, et al: Phase I study of paclitaxel as a 3-hour infusion followed by carboplatin in untreated patients with stage IV non-small cell lung cancer. Semin Oncol 22:48-54, 1995
35. Choy H, Rodriguez FF, Koester S, et al: Investigation of Taxol as a potential radiation sensitizer. Cancer 71:3774-3778, 1993
36. Milas L, Hunter NR, Mason KA, et al: Enhancement of tumor radioresponse of a murine mammary carcinoma by paclitaxel. Cancer Res 54:3506-3510, 1994
37. Kearns CM, Belani CP, Erkmen K, et al: Pharmacokinetics of paclitaxel and carboplatin in combination. Semin Oncol 22:1-4, 1995 (5 suppl 12)
38. Lopes NM, Adams EG, Pitts TW, et al: Cell kill kinetics and cell cycle effects of Taxol on human and hamster ovarian cell lines. Cancer Chemother Pharmacol 32:235-242, 1993
39. Liebman J, Cook JA, Fisher J, et al: In vitro studies of Taxol as a radiation sensitizer in human tumor cells. J Natl Cancer Inst 86:441-446, 1994
40. Cox JD, Stetz J, Pajak TF: Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for the Treatment and Research of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31:1341-1346, 1995
41. Zimmermann FB, Bamberg M, Molls M, et al: Radiation therapy alone in early stage non-small-cell lung cancer. Semin Surg Oncol 21:91-97, 2003
42. Hara R, Itami J, Kondo T, et al: Stereotactic single high dose irradiation of lung tumors under respiratory gating. Radiother Oncol 63:159-163, 2002
43. Whyte RI, Crownover R, Murphy MJ, et al: Stereotactic radiosurgery for lung tumors: Preliminary results of a phase I trial. Ann Thorac Surg 75:1097-1101, 2003
44. Hof H, Herfarth K, Munter M, et al: Stereotactic single-dose radiotherapy of stage I non-small-cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 56:3345-341, 2003
45. Uematsu M, Shioda A, Tahara K, et al: Focal, high-dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: A preliminary experience. Cancer 82:1062-1070, 1998
46. Fukumoto S, Shirato H, Shimizu S, et al: Small-volume image-guided radiotherapy using hypofractionated coplanar and noncoplanar multiple fields with inoperable stage I nonsmall cell lung carcinomas. Cancer 95:1546-1553, 2002
47. Uematsu M, Shioda A, Suda A, et al: Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small-cell lung cancer: A 5-year experience. Int J Radiat Oncol Biol Phys 51:666-670, 2001
48. Nagata Y, Negoro Y, Aoki T, et al: Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame. Int J Radiat Oncol Biol Phys 52:1041-1046, 2002
49. Lee S, Choi EK, Park HJ, et al: Stereotactic body frame based fractionated radiosurgery on consecutive days for primary or metastatic tumors in the lung. Lung Cancer 40:309-315, 2003
50. Onimaru R, Shirato H, Shimizu S, et al: Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers. Int J Radiat Oncol Biol Phys 56:126-135, 2003
51. Timmerman R, Papiez L, McGarry R, et al: Extracranial stereotactic radioablation: Results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 124:1946-1955, 2003
52. Wulf J, Hadinger U, Oppitz U, et al: Stereotactic radiotherapy of targets in the lung and liver. Strahlenther Onkol 177:645-655, 2001
53. Zimmermann F, Geinitz H, Schill S, et al: Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer. Lung Cancer 48:107-114, 2005
54. Jeremic B, Shibamoto Y, Milicic B, et al: Impact of treatment interruptions due to toxicity on outcome of patients with early stage (I/II) non-small-cell lung cancer (NSCLC) treated with hyperfractionated radiation therapy (Hfx RT) alone. Lung Cancer 40:317-323, 2003
55. Curran WJ Jr, Scott C, Langer C, et al: Phase III comparison of sequential vs concurrent chemoradiation for patients (pts) with unresected stage III non-small cell lung cancer (NSCLC): Initial report of Radiation Therapy Oncology Group (RTOG) 9410. Proc Am Soc Clin Oncol 19:484a, 2000 (abstract 1891)
56. Jeremio B, Shibamoto Y, Acimovic L, et al: Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer. J Clin Oncol 15:893-900, 1997
57. Jeremić B, Shibamoto Y, Nikolic N, et al: The role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer: A randomized study. J Clin Oncol 17:2092-2099, 1999
58. Jeremić B, Shibamoto Y, Stanisavljevic B, et al: Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: A prospective randomized trial. Radiother Oncol 43:29-37, 1997
59. Jeremić B, Shibamoto Y, Milicic B, et al: Hyperfractionated radiation therapy with or without concurrent low-dose cisplatin in locally advanced squamous cell carcinoma of the head and neck: A prospective randomized trial. J Clin Oncol 18:1458-1464, 2000
60. Hayakawa K, Mitsuhashi N, Katano S, et al: High-dose radiation therapy for elderly patients with inoperable or unresectable non-small cell lung cancer. Lung Cancer 32:81-88, 2001
61. Gauden SJ, Tripcony L: The curative treatment by radiation therapy alone of stage I non-small cell lung cancer in a geriatric population. Lung Cancer 32:71-79, 2001
62. Furuta M, Hayakawa K, Katano S, et al: Radiation therapy for stage I-II non-small cell lung cancer in patients aged 75 years and older. Jpn J Clin Oncol 26:95-98, 1996
63. Jeremić B, Milicic B, Acimovic L, et al: Concurrent hyperfractionated radiotherapy and low-dose daily carboplatin/paclitaxel in patients with stage III non-small cell lung cancer: Long-term results of a phase II study. J Clin Oncol 23:1144-1151, 2005